20.06.2011 • Videos

Thomas Gründemann of Ferak Berlin on Custom Synthesis Trends

Ferak Berlin CEO Thomas Grünemann took a few minutes at this year's Chemspec Europe in Geneva to talk to CHEManager Europe Editor-in-Chief Brandi Schuster about custom synthesis and his company's "one product per campaign" strategy.

Company

Ferak Berlin GmbH

Lahnstr. 34
12055 Berlin
Germany

Company contact







Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read